A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Haemonetics Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 27,486 shares of HAE stock, worth $2.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
27,486
Previous 26,032 5.59%
Holding current value
$2.2 Million
Previous $2.15 Million 2.6%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.45 - $91.58 $105,342 - $133,157
1,454 Added 5.59%
27,486 $2.21 Million
Q2 2024

Aug 14, 2024

BUY
$81.24 - $97.37 $2.11 Million - $2.53 Million
26,032 New
26,032 $2.15 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.11B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.